Mäki-Marttunen V, Nerland S, Jørgensen KN, Høgestøl EA, Rokicki J, Alnæs D, Borgwardt S, Boye B, Buitelaar J, Bøen E, Cervenka S, Conzelmann A, Erhardt S, Franke B, Celius EG, Harbo HF, Hilland E, Hoekstra P, Hartman CA, Jonassen R, Jönsson EG, Landrø NI, Lesch KP, Maglanoc LA, Pauli P et al. (2026)
Thalamic nuclei volumes across psychiatric and neurological disorders: a multi-site magnetic resonance imaging study
Transl Psychiatry (in press)
DOI 10.1038/s41398-026-04076-5, PubMed 42129147

Rasmussen TH, Schikora-Rustad S, Lorentzen ÅR, Tran TT, Øverås MH, Myhr KM, Wergeland S, Aarseth J, Bø L, Berge T, Høgestøl EA, Harbo HF, Tveter AT, Jørgensen KK, Cunen C, Torkildsen Ø, Holmøy T, Celius EG, Vaage JT, Nygaard GO, Lund-Johansen F, König M (2026)
Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study
BMJ Neurol Open, 8 (1), e001556
DOI 10.1136/bmjno-2026-001556, PubMed 41835014

Corona A, Clarelli F, Pääkkönen K, Harroud A, Shchetynsky K, Zollo A, Mingione A, Sorosina M, Mascia E, Giordano A, Rocca MA, Piehl F, Stridh P, Hemmer B, Goris A, Dubois B, Søndergaard HB, Sellebjerg F, D'alfonso S, Harbo HF, Olsson T, Saarela J, Priori A, Filippi M, Kockum I et al. (2026)
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study
Mult Scler, 13524585261417130 (in press)
DOI 10.1177/13524585261417130, PubMed 41776383